Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Everolimus in Relapsed Osteosarcoma
NCT01804374Phase 2Completed
- Sponsor
- Italian Sarcoma Group
- Start
- Jun 2011
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib, everolimus in osteosarcoma (OS), sponsored by Italian Sarcoma Group. Started Jun 2011; status: completed.
02
Drugs
sorafenibeverolimus
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT01804374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01804374.